Literature DB >> 19305224

Assessing quality across healthcare subsystems in Mexico.

Andrea Puig1, José A Pagán, Rebeca Wong.   

Abstract

Recent healthcare reform efforts in Mexico have focused on the need to improve the efficiency and equity of a fragmented healthcare system. In light of these reform initiatives, there is a need to assess whether healthcare subsystems are effective at providing high-quality healthcare to all Mexicans. Nationally representative household survey data from the 2006 Encuesta Nacional de Salud y Nutrición (National Health and Nutrition Survey) were used to assess perceived healthcare quality across different subsystems. Using a sample of 7234 survey respondents, we found evidence of substantial heterogeneity in healthcare quality assessments across healthcare subsystems favoring private providers over social security institutions. These differences across subsystems remained even after adjusting for socioeconomic, demographic, and health factors. Our analysis suggests that improvements in efficiency and equity can be achieved by assessing the factors that contribute to heterogeneity in quality across subsystems.

Entities:  

Mesh:

Year:  2009        PMID: 19305224      PMCID: PMC3296558          DOI: 10.1097/JAC.0b013e31819942e5

Source DB:  PubMed          Journal:  J Ambul Care Manage        ISSN: 0148-9917


  8 in total

Review 1.  A framework for assessing the performance of health systems.

Authors:  C J Murray; J Frenk
Journal:  Bull World Health Organ       Date:  2000       Impact factor: 9.408

2.  Addressing inequity in health and health care in Mexico.

Authors:  Mariana Barraza-Lloréns; Stefano Bertozzi; Eduardo González-Pier; Juan Pablo Gutiérrez
Journal:  Health Aff (Millwood)       Date:  2002 May-Jun       Impact factor: 6.301

3.  Household income and health care expenditures in Mexico.

Authors:  S W Parker; R Wong
Journal:  Health Policy       Date:  1997-06       Impact factor: 2.980

Review 4.  Bridging the divide: global lessons from evidence-based health policy in Mexico.

Authors:  Julio Frenk
Journal:  Lancet       Date:  2006-09-09       Impact factor: 79.321

Review 5.  Benchmarking of performance of Mexican states with effective coverage.

Authors:  Rafael Lozano; Patricia Soliz; Emmanuela Gakidou; Jesse Abbott-Klafter; Dennis M Feehan; Cecilia Vidal; Juan Pablo Ortiz; Christopher J L Murray
Journal:  Lancet       Date:  2006-11-11       Impact factor: 79.321

6.  Economic impact of antiretroviral therapy prescription decisions in the context of rapid scaling-up of access to treatment: lessons from Mexico.

Authors:  Sergio Bautista-Arredondo; Aditya Mane; Stefano M Bertozzi
Journal:  AIDS       Date:  2006-01-02       Impact factor: 4.177

Review 7.  Health metrics and evaluation: strengthening the science.

Authors:  Christopher J L Murray; Julio Frenk
Journal:  Lancet       Date:  2008-04-05       Impact factor: 79.321

8.  The epidemiologic transition. A theory of the epidemiology of population change.

Authors:  A R Omran
Journal:  Milbank Mem Fund Q       Date:  1971-10
  8 in total
  5 in total

1.  [Social inequalities in the progression of COVID-19 in the Mexican population].

Authors:  Luis Ortiz-Hernández; Miguel A Pérez-Sastré
Journal:  Rev Panam Salud Publica       Date:  2020-09-25

2.  Ambulatory health service users' experience of waiting time and expenditure and factors associated with the perception of low quality of care in Mexico.

Authors:  Alma Lucila Sauceda-Valenzuela; Veronika J Wirtz; Yared Santa-Ana-Téllez; Maria de la Luz Kageyama-Escobar
Journal:  BMC Health Serv Res       Date:  2010-06-23       Impact factor: 2.655

3.  Evaluation of Medical Care for Diabetic and Hypertensive Patients in Primary Care in Mexico: Observational Retrospective Study.

Authors:  Agustin Lara-Esqueda; Sergio A Zaizar-Fregoso; Violeta M Madrigal-Perez; Mario Ramirez-Flores; Daniel A Montes-Galindo; Margarita L Martinez-Fierro; Iram P Rodriguez-Sanchez; José Guzman-Esquivel; Carmen Meza-Robles; Gabriel Ceja-Espiritu; Pablo A Kuri-Morales; Josuel Delgado-Enciso; Armando Barriguete-Melendez; Hector R Galvan-Salazar; Carlos E Barajas-Saucedo; Elvin Guillermo-Espinosa; Agustin D Lara-Basulto; Jesus F Gonzalez-Roldan; Ivan Delgado-Enciso
Journal:  J Diabetes Res       Date:  2021-08-14       Impact factor: 4.011

4.  Ethnic disparities in COVID-19 mortality in Mexico: A cross-sectional study based on national data.

Authors:  Ismael Ibarra-Nava; Kathia G Flores-Rodriguez; Violeta Ruiz-Herrera; Hilda C Ochoa-Bayona; Alfonso Salinas-Zertuche; Magaly Padilla-Orozco; Raul G Salazar-Montalvo
Journal:  PLoS One       Date:  2021-03-10       Impact factor: 3.240

5.  Incremental Risk of Developing Severe COVID-19 Among Mexican Patients With Diabetes Attributed to Social and Health Care Access Disadvantages.

Authors:  Sandra G Sosa-Rubí; Jacqueline A Seiglie; Carlos Chivardi; Jennifer Manne-Goehler; James B Meigs; Deborah J Wexler; Veronika J Wirtz; Octavio Gómez-Dantés; Edson Serván-Mori
Journal:  Diabetes Care       Date:  2020-11-18       Impact factor: 17.152

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.